Elevated ROS levels can support the survival of tumor cells by activating the expression of transcription factors like nuclear factor erythroid 2-related factor (Nrf2), which initiates the upregulation of cellular antioxidant defenses to avert ROS-mediated damage, ultimately contributing to chemotherapy resistance [35,36]. The gene discussed is NFE2L2; the disease is neoplasm.